Search Results - "Pereverzeva, E. R."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Ascorbigen — Rifabutin Toxicity Modifier by Pereverzeva, E. R., Treshchalin, M. I., Treshchalin, I. D.

    Published in Antibiotiki i himioterapiâ (31-12-2020)
    “…Relevance . Indications for rifabutin use are constantly expanding. It is used in the treatment of extremely complex nosological forms of infectious diseases…”
    Get full text
    Journal Article
  2. 2

    Antitumor Activity and Toxicity of Olivamide Dosage Form, a New Semi-Synthetic Olivomycin a Derivative by Treshchalin, I. D., Treshchalin, M. I., Tevyashova, A. N., Pereverzeva, E. R.

    Published in Pharmaceutical chemistry journal (15-02-2019)
    “…Methods for selective chemical modification of the antibiotic olivomycin A (OA) were developed at G. F. Gause Institute of New Antibiotics. The compound with…”
    Get full text
    Journal Article
  3. 3

    Experimental Evaluation of Chronic Toxicity of Amphamide – a New Semisynthetic Derivative of Amphotericin B by Pereverzeva, E. R., Treshchalin, M. I., Bychkova, E. N., Tevyashova, A. N., Treshchalin, I. D.

    Published in Pharmaceutical chemistry journal (01-02-2020)
    “…Amphotericin B (AmB) remains a drug of first choice for treatment of most severe mycoses despite significant toxicity and solubility problems. Screening of a…”
    Get full text
    Journal Article
  4. 4

    Preclinical Pharmacokinetic and Toxicity Studies of Anthrafuran – A New Antitumor Agent by Portnoi, Yu. A., Dovzhenko, S. A., Kobrin, M. B., Pereverzeva, E. R., Treshchalin, M. I., Golibrodo, V. A., Shchekotikhin, A. E., Firsov, A. A.

    Published in Pharmaceutical chemistry journal (01-05-2020)
    “…The pharmacokinetics and acute toxicity of the new anthra[2, 3- b ]furan-3-carboxamide derivative anthrafuran (AF) were studied after intravenous (i.v.),…”
    Get full text
    Journal Article
  5. 5

    Use of Proteins to Increase the Aqueous Solubility of Rifapentine by Ostrovskii, K. P., Osipova, N. S., Vanchugova, L. V., Shipulo, E. V., Pereverzeva, É. R., Treshchalin, I. D., Maksimenko, O. O., Gel’perina, S. É.

    Published in Pharmaceutical chemistry journal (01-09-2016)
    “…Parenteral formulations of the poorly soluble antituberculosis antibiotic rifapentine were developed. Proteins (human serum albumin, succinylated gelatin, and…”
    Get full text
    Journal Article
  6. 6

    Efficacy of an Intravenous Form of Rifapentine in a Model of Experimental Tuberculosis in Mice by Ostrovskii, K. P., Osipova, N. S., Vanchugova, L. V., Shipulo, E. V., Potapov, V. D., Pereverzeva, É. R., Treshchalin, I. D., Maksimenko, O. O., Gel’perina, S. É.

    Published in Pharmaceutical chemistry journal (01-10-2017)
    “…Solubilization of rifapentine with human serum albumin (HSA) was used to produce a water-miscible form consisting of a colloidal suspension of particles of…”
    Get full text
    Journal Article
  7. 7

    Allergic and immunotoxic effects of calcium ketopantoyl aminobutyrate by Karaev, A L, Treshchalin, I D, Bodyagin, D A, Pereverzeva, E R, Kozlova, G S, Gunar, V I

    “…We studied the allergic and immunotoxic effects of a new promising medicinal preparation calcium ketopantoyl aminobutyrate. Calcium ketopantoyl aminobutyrate…”
    Get full text
    Journal Article
  8. 8

    Potential mutagenicity, embryotoxicity, and teratogenicity of calcium ketopantoyl aminobutyrate by Karaev, A L, Treshchalin, I D, Bodyagin, D A, Pereverzeva, E R, Kozlova, G S, Gunar, V I, Revazova, Yu A, Yurchenko, V V

    “…We studied mutagenic, embryotoxic, and teratogenic properties of calcium ketopantoyl aminobutyrate, a preparation proposed as a new drug. Long-term oral…”
    Get full text
    Journal Article
  9. 9

    Effect of a novel antineoplastic drug olipifat on antitumor immunity in mice by Bukhman, V M, Bodyagin, D A, Pereverzeva, E R, Treshchalin, I D, Isakova, E V, Krivosheev, S E, Reztsova, V V, Filov, V A

    “…Olipifat is an antineoplastic drug containing pyrophosphate and a product of special lignin processing. Donor C57Bl/6J mice with syngeneic B16 melanoma…”
    Get full text
    Journal Article
  10. 10

    Pathophysiological effects of psychoemotional stress and cyclophosphamide by Ingel', F. I., Bodyagin, D. A., Pereverzeva, E. R., Revazova, Yu. A.

    “…Effects arising in mice acutely or chronically exposed to cyclophosphamide, psychoemotional stress, or both are described. These factors produce similar…”
    Get full text
    Journal Article
  11. 11

    Fortification of antimicrobial barrier of the small intestine in newborn mice after oral administration of ascorbigen by Pereverzeva, E R, Mirchink, E P, Isakova, E B, Bukhman, V M, Preobrazhenskaia, M N

    “…Ascorbigen, a natural product, is an indole derivative of L-ascorbic acid. Its effect on postnatal development and antibacterial resistance of the small…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Toxicological Evaluation of Intravenous Formulation of Rifapentine by K. P. Ostrovskiy, E. R. Pereverzeva, I. D. Treshchalin, N. S. Osipova, M. I. Treshchalin, E. V. Voznyakovskaya, V. Yu. Balabanyan, O. O. Maksimenko, S. E. Gelperina

    “…Rifapentine belongs to the most potent antituberculosis drugs. Nevertheless, there are some limitations for its clinical use because of the low aqueous…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The influence of cyclophosphane and phenthyrine and their combination with zymosan and serotonin on the functional features distingusihing peritoneal macrophages in mice by Pereverzeva, E R

    Published in Farmakologiia i toksikologiia (01-06-1978)
    “…Radiometric analysis into phagocytic activity of macrophages in intact and tumourous mice following introduction to them of phenthyrine and cyclophosphane…”
    Get more information
    Journal Article
  16. 16
  17. 17

    The preclinical assessment of the activity and pharmacological action of native human interleukin-2 by Malakhova, N V, Treshchalin, I D, Iobadze, M S, Abronina, I F, Bykovskaia, S N, Iushkov, S F, Pereverzeva, E R, Syrkin, A B, Raushenbakh, M O

    “…It was demonstrated in in vivo and in vitro experiments that interleukin-2, obtained by cultivation of donor lymphocytes and purified by gel filtration,…”
    Get more information
    Journal Article
  18. 18

    Present-day goals and aims of the study of DNA levels in tumor cells by Petrova, A S, Pereverzev, B L, Zubrikhina, G N, Pereverzeva, E R, Kazanova, L I

    Published in Eksperimentalʹnaja onkologija (1984)
    “…Aims and tasks of the investigation of the DNA contents in tumour cells are discussed. It is supposed that DNA aneuploidia is a specific sign of malignant…”
    Get more information
    Journal Article